News

Dechra announces it has agreed to acquire Piedmont Animal Health, Inc.

Dechra (LSE: DPH) today announces it has agreed to acquire Piedmont Animal Health, Inc ("Piedmont"). Piedmont specializes in developing novel and differentiated products for the companion animal market and has a strong development track record. Piedmont specializes in developing novel and differentiated companion animal products ("CAP") with significant growth potential. Originally founded in 2001 in Greensboro, North Carolina, it has a long and successful track record of product development including major brands launched by multi-national animal health companies. Piedmont employs a development team of 19 people, increasing Dechra's scientific and regulatory capabilities.

Dechra Announces VOHC Acceptance for Water Additive

Dechra Veterinary Products is pleased to announce that its VETRADENT® Liquid Water Additive has received the seal of acceptance to Help Control Tartar from the Veterinary Oral Health Council (VOHC). The seal has been granted for dogs after properly demonstrating both safety and efficacy.

Taking steps today for a greener tomorrow

Dechra is working on making a difference through sustainable improvements in global animal health and welfare. As such, we created a guide with tips to help Veterinarians and their teams diminish their global impact on the environment. If you are a Veterinarian and would like more information, please contact your Dechra representative

Dechra proudly introduces Mirataz: Veterinary licensed transdermal medication for feline weight control

Unintended weight loss is the #3 reason for pet owners to bring their cat to the veterinarian. Controlling rapid weight loss is critical, and to date has depended on off-label use of oral human medications, which can be difficult to administer and dose accurately.

Dechra Veterinary Products Partners with I-MED Pharma

Dechra Veterinary Products is pleased to announce its exclusive marketing, sales, and distribution agreement with I-MED Pharma, the Canadian leader in dry eye management, for three innovative veterinary hyaluronic acid (HA) ophthalmic products.

Brand new Dechra Academy launches

Dechra is pleased to announce that the brand new Dechra Academy is now live.

NEW! Atipam

ATIPAM is an injectable 5 mg/mL Atipamezole Hydrochloride solution indicated for the reversal of the clinical effects of dexmedetomidine hydrochloride and medetomidine hydrochloride in dogs.

COVID-19 update

As the situation with regard to COVID-19 continues to evolve we would like to outline the steps that we are taking to protect our employees, to maintain product supply and services to our customers and to provide support to the overall effort to combat the virus by the health sector. At this point in time we will not be furloughing employees, nor will we be taking financial support from any government body as we believe that the Company will remain financially sound in the immediate future.

NEW! Osurnia

Dechra Veterinary Products extends its otitis range with the addition of OSURNIA® (florfenicol-terbinafine-betamethasone acetate)

NEW! CosACTHen

Introducing a veterinary licensed testing solution for Addison’s and Cushing’s disease.